NWK Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14M Sell
15,174
-193
-1% -$196K 5.36% 5
2025
Q4
$16.5M Sell
15,367
-51
-0.3% -$48.8K 5.74% 3
2025
Q3
$11.8M Sell
15,418
-41
-0.3% -$30.5K 4% 9
2025
Q2
$12.1M Sell
15,459
-48
-0.3% -$37.3K 4.23% 9
2025
Q1
$12.8M Sell
15,507
-431
-3% -$359K 5.86% 5
2024
Q4
$12.3M Buy
15,938
+138
+0.9% +$114K 4.75% 6
2024
Q3
$14M Sell
15,800
-136
-0.9% -$122K 5.7% 3
2024
Q2
$14.4M Sell
15,936
-135
-0.8% -$108K 6.06% 2
2024
Q1
$12.5M Buy
16,071
+384
+2% +$273K 5.86% 2
2023
Q4
$9.14M Buy
15,687
+285
+2% +$166K 4.7% 6
2023
Q3
$8.27M Sell
15,402
-2,832
-16% -$1.46M 5.08% 6
2023
Q2
$8.55M Sell
18,234
-70
-0.4% -$29.4K 5.01% 4
2023
Q1
$6.29M Sell
18,304
-135
-0.7% -$45.5K 4.08% 5
2022
Q4
$6.75M Buy
18,439
+67
+0.4% +$23.8K 4.96% 4
2022
Q3
$5.94M Sell
18,372
-623
-3% -$197K 4.6% 6
2022
Q2
$6.16M Buy
18,995
+192
+1% +$57.6K 4.15% 6
2022
Q1
$5.38M Buy
18,803
+12,751
+211% +$3.28M 2.91% 14
2021
Q4
$1.67M Buy
+6,052
New +$1.53M 0.62% 36

Other funds holding LLY

NWK Group's LLY Position: Q1 2026 in Review

NWK Group reduced its Eli Lilly (LLY) stake by 1.3% in Q1 2026, selling an estimated $196K and leaving 15,174 shares worth $14M. The position accounts for 5.36% of the portfolio, ranked #5.

NWK Group first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $16.5M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • NWK Group held 15,174 shares of Eli Lilly worth $14M as of Q1 2026.
  • NWK Group sold 193 Eli Lilly shares in Q1 2026, an estimated $196K.
  • Eli Lilly made up 5.36% of NWK Group's portfolio in Q1 2026, its #5 holding.
  • NWK Group first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • NWK Group's Eli Lilly position peaked at $16.5M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on NWK Group's 13F filing for Q1 2026, filed 7 May 2026.